Parallels between cancer and infectious disease

New England Journal of Medicine

Volumn 371, Issue 4, 2014, Pages 380-383

  Hotchkiss, Richard S ^a   Moldawer, Lyle L ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ADVANCED CANCER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; EARLY CANCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOSTIMULATION; LATENT VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION;

ANIMALS; BACTERIAL INFECTIONS; COMMUNICABLE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; MICE; NEOPLASMS; T-LYMPHOCYTES; VIRAL LOAD; VIRUS DISEASES;

EID: 84904549329     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr1404664     Document Type: Article

References (7)

1. Matsushita H, Vesely MD, Koboldt DC, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 2012;482:400-4.
2. Cheever MA. Twelve immunotherapy drugs that could cure cancers. Immunol Rev 2008;222:357-68. (Pubitemid 351430366)
3. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12:252-64.
4. + T cell dysfunction during chronic infection. Immunity 2014;40:289-302.
5. De Vlaminck I, Khush KK, Strehl C, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell 2013;155:1178-87.
6. Patel A, Patel J, Ikwuagwu J. A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. J Antimicrob Chemother 2010;65:2697-8.
7. Merck enters strategic collaborations with Amgen, Incyte, and Pfizer to evaluate novel combination anti-cancer regimens with MK-3475. Wall Street Journal. February 5, 2014 (http://online.wsj.com/article/PR-CO-20140205-905936. html).